← All trials
NCT06054633
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2023
- Primary completion
- Oct 30, 2024
- Completion date
- Jan 31, 2025
- First posted
- Sep 26, 2023
- Last posted
- Sep 26, 2023
- Enrollment
- 100
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Central South UniversityLead sponsor
- Harvard UniversityCollaborator
- Memorial University of NewfoundlandCollaborator
- Shengjing HospitalCollaborator
- Central South UniversityOverall official - principal investigator
- University of NottinghamCollaborator
- Central South UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.